Abstrakt

The gastrointestinal (GI) tract contains the highest concentration of biogenic amines in the human body. Neurons located in the GI tract, modulated by biogenic amines and various peptide and non-peptide transmitters, are called Enteric Nervous System (ENS). That explains why many medications used in neurology and psychiatry present side effects from the gut. Serotonin (5-hyroxytrypatamine, 5-HT), 95% of which is synthesized in the gut, is the most important amine (beside epinephrine and norepinephrine) colon functionality but another substances such as histamine, dopamine and melatonin are also potent in modulating intestine’s actions. Over 30 receptors for 5-HT were described in the human body, and 5-HT3, 5-HT4 and 5-HT7 are known to have the highest influence on motility and are a potent target for the drugs for treatment GI disorders, such as Irritable Bowel Syndrome (IBS) and Inflammatory Bowel Diseases (IBD). Histamine is a key biogenic amine for pathogenesis of allergy also in the colon. Alteration in histaminergic system is found in patients with diarrhea and allergic enteropathy. Dopamine affects functions of the large intestine but its modulating actions are more presented in the upper part of GI tract. Melatonin is best known for regulating circadian circle, but may also be a potent anti-inflammatory agent within the gut. Despite many years of research, it seems that more studies are needed to fully understand human colon neurochemistry.

Przypisy

• 1. Aguilar M.J., Morales-Olivas F.J., Rubio E.: Pharmacological investigationinto the effects of histamine and histamine analogueson guinea-pig and rat colon in vitro. Br. J. Pharmacol., 1986; 88:501–506
  Google Scholar
• 2. Akyuz C., Yasar N.F., Uzun O., Peker K.D., Sunamak O., DumanM., Sehirli A.O., Yol S.: Effects of melatonin on colonic anastomosishealing following chemotherapy in rats. Singapore Med. J.,2018; 59: 545–549
  Google Scholar
• 3. Auteri M., Zizzo M.G., Amato A., Serio R.: Dopamine inducesinhibitory effects on the circular muscle contractility of mousedistal colon via D1- and D2-like receptors. J. Physiol. Biochem.,2016; 73: 395–404
  Google Scholar
• 4. Barbara G., Cremon C., De Giorgio R., Dothel G., Zecchi L., BellacosaL., Carini G., Stanghellini V., Corinaldesi R.: Mechanismsunderlying visceral hypersensitivity in irritable bowel syndrome.Curr. Gastroenterol. Rep., 2011; 13: 308–315
  Google Scholar
• 5. Barger G., Dale H.H.: Chemical structure and sympathomimeticaction of amines. J. Physiol., 1910; 41: 19–59
  Google Scholar
• 6. Bearcroft C.P., Perrett D., Farthing M.J.: Postprandial plasma5-hydroxytryptamine in diarrhoea predominant irritable bowelsyndrome: A pilot study. Gut, 1998; 42: 42–46
  Google Scholar
• 7. Beaulieu J.M., Gainetdinov R.R.: The physiology, signaling, andpharmacology of dopamine receptors. Pharmacol. Rev., 2011; 63:182–217
  Google Scholar
• 8. Breunig E., Michel K., Zeller F., Seidl S., Weyhern C.W., SchemannM.: Histamine excites neurones in the human submucous plexusthrough activation of H1, H2, H3 and H4 receptors. J. Physiol.,2007; 583: 731–742
  Google Scholar
• 9. Bubenik G.A.: Thirty four years since the discovery of gastrointestinalmelatonin. J. Physiol. Pharmacol., 2008; 59: 33–51
  Google Scholar
• 10. Bülbring E., Crema A.: Observations concerning the action of5-hydroxytryptamine on the peristaltic reflex. Br. J. Pharmacol.Chemother., 1958; 13: 444–457
  Google Scholar
• 11. Bülbring E., Crema A.: The release of 5-hydroxytryptamine inrelation to pressure exerted on the intestinal mucosa. J. Physiol.,1959; 146: 18–28
  Google Scholar
• 12. Bülbring E., Lin R.C.: The effect of intraluminal application of5-hydroxytryptamine and 5-hydroxytryptophan on peristalsis; thelocal production of 5-HT and its release in relation to intraluminalpressure and propulsive activity. J. Physiol., 1958; 140: 381–407
  Google Scholar
• 13. Chamanara M., Rashidian A., Mehr S.E., Dehpour A.R., ShirkohiR., Akbarian R., Abdollahi A., Rezayat S.M.: Melatonin amelioratesTNBS-induced colitis in rats through the melatonin receptors:Involvement of TLR4/MyD88/NF-κB signalling pathway. Inflammopharmacology,2019; 27: 361–371
  Google Scholar
• 14. Chen C.Q., Fichna J., Bashashati M., Li Y.Y., Storr M.: Distribution,function and physiological role of melatonin in the lower gut.World J. Gastroenterol., 2011; 17: 3888–3898
  Google Scholar
• 15. Chen J.X., Pan H., Rothman T.P., Wade P.R., Gershon M.D.:Guinea pig 5-HT transporter: Cloning, expression, distribution,and function in intestinal sensory reception. Am. J. Physiol., 1998;275: G433–G448
  Google Scholar
• 16. Chojnacki C., Błasiak J., Fichna J., Chojnacki J., Popławski T.:Evaluation of melatonin secretion and metabolism exponents inpatients with ulcerative and lymphocytic colitis. Molecules, 2018;23: 272
  Google Scholar
• 17. Chojnacki C., Walecka-Kapica E., Lokieć K., Pawłowicz M.,Winczyk K., Chojnacki J., Klupińska G.: Influence of melatonin onsymptoms of irritable bowel syndrome in postmenopausal women.Endokrynol. Pol., 2013; 64: 114–120
  Google Scholar
• 18. Chojnacki C., Wisniewska-Jarosinska M., Walecka-Kapica E.,Klupinska G., Jaworek J., Chojnacki J.: Evaluation of melatonin effectivenessin the adjuvant treatment of ulcerative colitis. J. Physiol.Pharmacol., 2011; 62: 327–334
  Google Scholar
• 19. Coates M.D., Mahoney C.R., Linden D.R., Sampson J.E., Chen J.,Blaszyk H., Crowell M.D., Sharkey K.A., Gershon M.D., Mawe G.M.,Moses P.L.: Molecular defects in mucosal serotonin content anddecreased serotonin reuptake transporter in ulcerative colitis andirritable bowel syndrome. Gastroenterology, 2004; 126: 1657–1664
  Google Scholar
• 20. Coates M.D., Tekin I., Vrana K.E., Mawe G.M.: Review article:The many potential roles of intestinal serotonin (5-hydroxytryptamine,5-HT) signalling in inflammatory bowel disease. Aliment.Pharmacol. Ther., 2017; 46: 569–580
  Google Scholar
• 21. Costedio M.M., Coates M.D., Danielson A.B., Buttolph T.R.3rd,Blaszyk H.J., Mawe G.M., Hyman N.H.: Serotonin signaling in diverticulardisease. J. Gastrointest. Surg., 2008; 12: 1439–1445
  Google Scholar
• 22. Deiteren A., De Man J.G., Pelckmans P.A., De Winter B.Y.: HistamineH4 receptors in the gastrointestinal tract. Br. J. Pharmacol.,2015; 172: 1165–1178
  Google Scholar
• 23. Deiteren A., De Man J.G., Ruyssers N.E., Moreels T.G., PelckmansP.A., De Winter B.Y.: Histamine H4 and H1 receptors contributeto postinflammatory visceral hypersensitivity. Gut, 2014;63: 1873–1882
  Google Scholar
• 24. Dunlop S.P., Coleman N.S., Blackshaw E., Perkins A.C., Singh G.,Marsden C.A., Spiller R.C.: Abnormalities of 5-hydroxytryptaminemetabolism in irritable bowel syndrome. Clin. Gastroenterol. Hepatol.,2005; 3: 349–357
  Google Scholar
• 25. Dunlop S.P., Jenkins D., Neal K.R., Spiller R.C.: Relative importanceof enterochromaffin cell hyperplasia, anxiety, and depressionin postinfectious IBS. Gastroenterology, 2003; 125: 1651–1659
  Google Scholar
• 26. Eisenhofer G., Aneman A., Friberg P., Hooper D., Fåndriks L.,Lonroth H., Hunyady B., Mezey E.: Substantial production of dopaminein the human gastrointestinal tract. J. Clin. Endocrinol.Metab., 1997; 82: 3864–3871
  Google Scholar
• 27. Esteban-Zubero E., López-Pingarrón L., Alatorre- JimenézM.A., Ochoa-Moneo P., Buisac-Ramón C., Rivas- Jimenéz M., Castán-Ruiz S., Antoñanzas-Lombarte A., Tan D.X., García J.J., Reiter R.J.:Melatonin’s role as a co-adjuvant treatment in colonic diseases:A review. Life. Sci., 2017; 170: 72–81
  Google Scholar
• 28. Fabisiak A., Wlodarczyk J., Fabisiak N., Storr M., Fichna J.: Targetinghistamine receptors in irritable bowel syndrome: A criticalappraisal. J. Neurogastroenterol. Motil., 2017; 23: 341–348
  Google Scholar
• 29. Fakhfouri G., Rahimian R., Daneshmand A., Bahremand A., RasouliM.R., Dehpour A.R., Mehr S.E., Mousavizadeh K.: Granisetronameliorates acetic acid-induced colitis in rats. Hum. Exp. Toxicol.,2010; 29: 321–328
  Google Scholar
• 30. Fernández-Gil B., Moneim A.E., Ortiz F., Shen Y.Q., Soto-MercadoV., Mendivil-Perez M., Guerra-Librero A., Acuña-CastroviejoD., Molina-Navarro M.M., García-Verdugo J.M., Sayed R.K., FloridoJ., Luna J.D., López L.C., Escames G.: Melatonin protects rats fromradiotherapy-induced small intestine toxicity. PLoS One, 2017;12: e0174474
  Google Scholar
• 31. Gershon M.D., Tack J.: The serotonin signaling system: Frombasic understanding to drug development for functional GI disorders.Gastroenterology, 2007; 132: 397–414
  Google Scholar
• 32. Ghia J.E., Li N., Wang H., Collins M., Deng Y., El-Sharkawy R.T.,Côté F., Mallet J., Khan W.I.: Serotonin has a key role in pathogenesisof experimental colitis. Gastroenterology, 2009; 137: 1649–1660
  Google Scholar
• 33. Greig C.J., Zhang L., Cowles R.A.: Potentiated serotonin signalingin serotonin re-uptake transporter knockout mice increasesenterocyte mass and small intestinal absorptive function. Physiol.Rep., 2019; 7: e14278
  Google Scholar
• 34. Hoffman J.M., Tyler K., MacEachern S.J., Balemba O.B., JohnsonA.C., Brooks E.M., Zhao H., Swain G.M., Moses P.L., GalliganJ.J., Sharkey K.A., Greenwood-Van Meerveld B., Mawe G.M.: Activationof colonic mucosal 5-HT4 receptors accelerates propulsivemotility and inhibits visceral hypersensitivity. Gastroenterology,2012; 142: 844–854
  Google Scholar
• 35. Irving H.R., Tan Y.Y., Tochon-Danguy N., Liu H., Chetty N.,Desmond P.V., Pouton C.W., Coupar I.M.: Comparison of 5-HT4 and5-HT7 receptor expression and function in the circular muscle ofthe human colon. Life. Sci., 2007; 80: 1198–1205
  Google Scholar
• 36. Keely S.J., Stack W.A., O’Donoghue D.P., Baird A.W.: Regulationof ion transport by histamine in human colon. Eur. J. Pharmacol.,1995; 279: 203–209
  Google Scholar
• 37. Kendig D.M., Grider J.R.: Serotonin and colonic motility. Neurogastroenterol.Motil., 2015; 27: 899–905
  Google Scholar
• 38. Kim D., Kim W., Jeong S., Kim D., Yoo J.W., Jung Y.: Therapeuticswitching of sulpiride, an anti-psychotic and prokinetic drug, toan anti-colitic drug using colon-specific drug delivery. Drug Deliv.Transl. Res., 2019; 9: 334–343
  Google Scholar
• 39. Kim H., Dwyer L., Song J.H., Martin-Cano F.E., Bahney J., PeriL., Britton F.C., Sanders K.M., Koh S.D.: Identification of histaminereceptors and effects of histamine on murine and simian colonicexcitability. Neurogastroenterol. Motil., 2011; 23: 949–e409
  Google Scholar
• 40. Kim J.J., Bridle B.W., Ghia J.E., Wang H., Syed S.N., ManochaM.M., Rengasamy P., Shajib M.S., Wan Y., Hedlund P.B., Khan W.I.:Targeted inhibition of serotonin type 7 (5-HT7) receptor functionmodulates immune responses and reduces the severity of intestinalinflammation. J. Immunol., 2013; 190: 4795–4804
  Google Scholar
• 41. Kuhne S., Wijtmans M., Lim H.D., Leurs R., de Esch I.J.: Severaldown, a few to go: Histamine H3 receptor ligands making the finalpush towards the market? Expert. Opin. Investig. Drugs, 2011;20: 1629–1648
  Google Scholar
• 42. Lanfranchi G.A., Marzio L., Cortini C., Osset E.M.: Motor effectof dopamine on human sigmoid colon. Evidence for specific receptors.Am. J. Dig. Dis., 1978; 23: 257–263
  Google Scholar
• 43. Li N., Ghia J.E., Wang H., McClemens J., Cote F., Suehiro Y.,Mallet J., Khan W.I.: Serotonin activates dendritic cell function inthe context of gut inflammation. Am. J. Pathol., 2011; 178: 662–671
  Google Scholar
• 44. Li Y., Zhang Y., Zhang X.L., Feng X.Y., Liu C.Z., Zhang X.N., QuanZ.S., Yan J.T., Zhu J.X.: Dopamine promotes colonic mucus secretionthrough dopamine D5 receptor in rats. Am. J. Physiol. Cell.Physiol., 2019; 316: C393–C403
  Google Scholar
• 45. Li Z., Chalazonitis A., Huang Y.Y., Mann J.J., Margolis K.G., YangQ.M., Kim D.O., Côté F., Mallet J., Gershon M.D.: Essential roles ofenteric neuronal serotonin in gastrointestinal motility and the development/survival of enteric dopaminergic neurons. J. Neurosci.,2011; 31: 8998–9009
  Google Scholar
• 46. Li Z.S., Schmauss C., Cuenca A., Ratcliffe E., Gershon M.D.: Physiologicalmodulation of intestinal motility by enteric dopaminergicneurons and the D2 receptor: Analysis of dopamine receptorexpression, location, development, and function in wild-type andknock-out mice. J. Neurosci., 2006; 26: 2798–2807
  Google Scholar
• 47. Liu C.Z., Zhang X.L., Zhou L., Wang T., Quan Z.S., Zhang Y., Li J.,Li G.W., Zheng L.F., Li L.S., Zhu J.X.: Rasagiline, an inhibitor of MAOB,decreases colonic motility through elevating colonic dopaminecontent. Neurogastroenterol. Motil., 2018; 30: e13390
  Google Scholar
• 48. Liu M., Geddis M.S., Wen Y., Setlik W., Gershon M.D.: Expressionand function of 5-HT4 receptors in the mouse enteric nervoussystem. Am. J. Physiol. Gastrointest. Liver Physiol., 2005; 289:G1148–G1163
  Google Scholar
• 49. Liu M.T., Kuan Y.H., Wang J., Hen R., Gershon M.D.: 5-HT4 receptor-mediated neuroprotection and neurogenesis in the entericnervous system of adult mice. J. Neurosci., 2009; 29: 9683–9699
  Google Scholar
• 50. Lu W.Z., Gwee K.A., Moochhalla S., Ho K.Y.: Melatonin improvesbowel symptoms in female patients with irritable bowelsyndrome: A double-blind placebo-controlled study. Aliment. Pharmacol.Ther, 2005; 22: 927–934
  Google Scholar
• 51. Magro F., Vieira-Coelho M.A., Fraga S., Serrão M.P., Veloso F.T.,Ribeiro T., Soares-da-Silva P.: Impaired synthesis or cellular storageof norepinephrine, dopamine, and 5-hydroxytryptamine inhuman inflammatory bowel disease. Dig. Dis. Sci., 2002; 47: 216–224
  Google Scholar
• 52. Margolis K.G., Li Z., Stevanovic K., Saurman V., Israelyan N.,Anderson G.M., Snyder I., Veenstra-VanderWeele J., Blakely R.D.,Gershon M.D.: Serotonin transporter variant drives preventablegastrointestinal abnormalities in development and function. J.Clin. Invest., 2016; 126: 2221-2235
  Google Scholar
• 53. Margolis K.G., Stevanovic K., Li Z., Yang Q.M., Oravecz T., ZambrowiczB., Jhaver K.G., Diacou A., Gershon M.D.: Pharmacologicalreduction of mucosal but not neuronal serotonin opposes inflammationin mouse intestine. Gut, 2014; 63: 928–937
  Google Scholar
• 54. Martin A.M., Lumsden A.L., Young R.L., Jessup C.F., SpencerN.J., Keating D.J.: Regional differences in nutrient-induced secretionof gut serotonin. Physiol. Rep., 2017; 5: e13199
  Google Scholar
• 55. Mawe G.M., Hoffman J.M.: Serotonin signalling in the gut –functions, dysfunctions and therapeutic targets. Nat. Rev. Gastroenterol.Hepatol. 2013; 10: 473–486
  Google Scholar
• 56. Miwa J., Echizen H., Matsueda K., Umeda N.: Patients with constipation-predominant irritable bowel syndrome (IBS) may haveelevated serotonin concentrations in colonic mucosa as comparedwith diarrhea-predominant patients and subjects with normalbowel habits. Digestion., 2001; 63: 188–194
  Google Scholar
• 57. Mousavizadeh K., Rahimian R., Fakhfouri G., Aslani F.S., GhafourifarP.: Anti-inflammatory effects of 5-HT receptor antagonist,tropisetron on experimental colitis in rats. Eur. J Clin. Invest.,2009; 39: 375–383
  Google Scholar
• 58. Riley J.F., West G.B.: Histamine in tissue mast cells. J. Physiol.,1952; 117: 72P–73P
  Google Scholar
• 59. Saha L., Malhotra S., Rana S., Bhasin D., Pandhi P.: A preliminarystudy of melatonin in irritable bowel syndrome. J. Clin. Gastroenterol.,2007; 41: 29–32
  Google Scholar
• 60. Salaga M., Binienda A., Piscitelli F., Mokrowiecka A., CygankiewiczA.I., Verde R., Malecka-Panas E., Kordek R., Krajewska W.M., DiMarzo V., Fichna J.: Systemic administration of serotonin exacerbatesabdominal pain and colitis via interaction with the endocannabinoidsystem. Biochem. Pharmacol., 2019; 161: 37–51
  Google Scholar
• 61. Sander L.E., Lorentz A., Sellge G., Coëffier M., Neipp M., VeresT., Frieling T., Meier P.N., Manns M.P., Bischoff S.C.: Selective expressionof histamine receptors H1R, H2R, and H4R, but not H3R,in the human intestinal tract. Gut, 2006; 55: 498–504
  Google Scholar
• 62. Shajib M.S., Chauhan U., Adeeb S., Chetty Y., Armstrong D.,Halder S.L.S., Marshall J.K., Khan W.I.: Characterization of serotoninsignaling components in patients with inflammatory boweldisease. J. Can. Assoc. Gastroenterol., 2019; 2: 132–140
  Google Scholar
• 63. Shang B., Shi H., Wang X., Guo X., Wang N., Wang Y., DongL.: Protective effect of melatonin on myenteric neuron damagein experimental colitis in rats. Fundam. Clin. Pharmacol., 2016;30: 117–127
  Google Scholar
• 64. Singaram C., Ashraf W., Gaumnitz E.A., Torbey C., Sengupta A.,Pfeiffer R., Quigley E.M.: Dopaminergic defect of enteric nervoussystem in Parkinson’s disease patients with chronic constipation.Lancet, 1995; 346: 861–864
  Google Scholar
• 65. Smith T.K., Dickson E.J., Heredia D.J., Hennig G.W., BayguinovP.O.: Controversies involving the role of 5-hydroxytryptamine ingenerating colonic migrating motor complexes: What is spontaneous?Gastroenterology, 2010; 138: 1213–1214
  Google Scholar
• 66. Söderquist F., Hellström P.M., Cunningham J.L.: Human gastroenteropancreaticexpression of melatonin and its receptors MT1and MT2. PLoS One, 2015; 10: e0120195
  Google Scholar
• 67. Song G.H., Leng P.H., Gwee K.A., Moochhala S.M., Ho K.Y.: Melatoninimproves abdominal pain in irritable bowel syndrome patientswho have sleep disturbances: A randomised, double blind,placebo controlled study. Gut, 2005; 54: 1402–1407
  Google Scholar
• 68. Spiller R.C., Jenkins D., Thornley J.P., Hebden J.M., Wright T.,Skinner M., Neal K.R.: Increased rectal mucosal enteroendocrinecells, T lymphocytes, and increased gut permeability followingacute Campylobacter enteritis and in post-dysenteric irritablebowel syndrome. Gut, 2000; 47: 804–811
  Google Scholar
• 69. Sullivant A., Mackin A., Pharr T., Cooley J., Wills R., Archer T.:Identification of histamine receptors in the canine gastrointestinaltract. Vet. Immunol. Immunopathol., 2016; 182: 29–36
  Google Scholar
• 70. Thor P.J., Krolczyk G., Gil K., Zurowski D., Nowak L.: Melatoninand serotonin effects on gastrointestinal motility. J. Physiol. Pharmacol.,2007; 58: 97–103
  Google Scholar
• 71. Tolstanova G., Deng X., Ahluwalia A., Paunovic B., PrysiazhniukA., Ostapchenko L., Tarnawski A., Sandor Z., Szabo S.: Role of dopamine and D2 dopamine receptor in the pathogenesis of inflammatorybowel disease. Dig. Dis. Sci., 2015; 60: 2963–2975
  Google Scholar
• 72. Twarog B.M., Page I.H.: Serotonin content of some mammaliantissues and urine and a method for its determination. Am. J.Physiol., 1953; 175: 157–161
  Google Scholar
• 73. Vaughan C.J., Aherne A.M., Lane E., Power O., Carey R.M.,O’Connell D.P.: Identification and regional distribution of the dopamineD1A receptor in the gastrointestinal tract. Am. J. Physiol.Regul. Integr. Comp. Physiol., 2000; 279: R599–R609
  Google Scholar
• 74. Walker J.K., Gainetdinov R.R., Mangel A.W., Caron M.G., ShetzlineM.A.: Mice lacking the dopamine transporter display alteredregulation of distal colonic motility. Am. J. Physiol. Gastrointest.Liver Physiol., 2000; 279: G311–G318
  Google Scholar
• 75. Walther D.J., Peter J.U., Bashammakh S., Hörtnagl H., Voits M.,Fink H., Bader M.: Synthesis of serotonin by a second tryptophanhydroxylase isoform. Science, 2003; 299: 76
  Google Scholar
• 76. Wu H., Liu J., Yin Y., Zhang D., Xia P., Zhu G.: Therapeutic opportunitiesin colorectal cancer: Focus on melatonin antioncogenicaction. Biomed. Res. Int., 2019; 2019: 9740568
  Google Scholar
• 77. Yaakob N.S., Chinkwo K.A., Chetty N., Coupar I.M., Irving H.R.:Distribution of 5-HT3, 5-HT4, and 5-HT7 receptors along the humancolon. J. Neurogastroenterol. Motil., 2015; 21: 361–369
  Google Scholar
• 78. Yang Y., Kim W., Kim D., Jeong S., Yoo J.W., Jung Y.: A colonspecificprodrug of metoclopramide ameliorates colitis in an experimentalrat model. Drug Des. Dev. Ther., 2018; 13: 231–242
  Google Scholar
• 79. Zhang X., Guo H., Xu J., Li Y., Li L., Zhang X., Li X., Fan R.,Zhang Y., Duan Z., Zhu J.: Dopamine receptor D1 mediates the inhibitionof dopamine on the distal colonic motility. Transl. Res.,2012; 159: 407–414
  Google Scholar
• 80. Zielińska M., Jarmuż A., Sałaga M., Kordek R., Laudon M., StorrM., Fichna J.: Melatonin, but not melatonin receptor agonists Neu-P11 and Neu-P67, attenuates TNBS-induced colitis in mice. NaunynSchmiedebergs Arch. Pharmacol., 2016; 389: 511–519
  Google Scholar
• 81. Zizzo M.G., Bellanca A., Amato A., Serio R.: Opposite effectsof dopamine on the mechanical activity of circular and longitudinalmuscle of human colon. Neurogastroenterol. Motil., 2020;32: e13811
  Google Scholar

Pełna treść artykułu